The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are:
Will the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block.
Participants will:
Read the information Participants have been given about the sphenopalatine ganglion block.
In case of any side effects, please contact participant's doctor.
Participants who will undergo septoplasty
18 to 50 years old
ASA score 1 or 2
Under 18 or over 50 years of age
ASA score III and above patient group
The patient is allergic to any of the drugs used
The patient has a contraindication to any of the drugs used
Parallel
Sphenopalatine Ganglion Block
Procedure/SurgerySphenopalatine ganglion block group 4cc (80mg) 2% lidocaine + 1cc (4mg) dexamethasone in total 5cc volume will be prepared under sterile conditions before the procedure, 2.5 cc will be given to both nostrils. Sphenopalatine ganglion block will be applied by transnasal endoscopic method.
visual analogue scale
Zero is equivalent to no pain and 10 indicates the worst possible pain.
total amount of tramadol consumption
Total tramadol consumption will be recorded in the postoperative period by fitting participants with a patient-controlled analgesia device.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
